SF0426OA6643/072026
13/07/2028
Active ingredient:
Ketorolac Tromethamine 30 mg.
Therapeutic indications:
Indicated for the short-term (5-days) management of moderately severe acute pain that requires analgesia at the opioid level, usually in a
postoperative setting.
Dosage form
Solution for I.M or I.V Injection.
Active ingredient:12.5 mg diclofenac sodium Therapeutic indications: Dosage formsuppositories
Read More
Active ingredient:40 mg pantoprazole Therapeutic indications: Indicated for reflux oesophagitis,...
Read More
Factory Locations
Quick Links
© 2024 All rights reserved @PHARO PHARMA
Terms and Conditions | Privacy Policy
